We're excited to be in Dublin for the EASLnews #NAFLDSummit! Looking forward to three days of engaging panels, new data and a productive dialogue on all things #NAFLD & #NASH! #LiverTwitter

We're growing again! Come be part of an incredible team during SUCH an exciting time in #space! missioncontrolspaceservices.com/about/careers/ #hiring

Is your organization looking for a new agency or a new perspective for your medical communications partner? Have a look at our article "Choosing the Right Medical Communications Agency" to learn what to look for during the selection process. bit.ly/3CxucL4

Registration and abstract submission is open for the 2nd annual Advances in Hypoglycaemia Scientific Conference virtual meeting on Nov. 16-17! This conference is your chance to learn and connect with the #hypoglycaemia research community. Sign up here: web.cvent.com/event/ef938739…

Such an awesome opportunity for health researchers to improve their #SciComm skills! Kudos to CIHR for recognizing the importance of science communications 👏🏼👏🏼

It's Robin's special day! Our Chief Exec keeps us on track and motivated towards our mission, values, and goals, while also being a hands-on presence for our clients and their projects. Frankly, Robin, we don't know how you do it! Happy Birthday!

Two NASH drugs are on the horizon for market approval within 12 months. Is your practice ready? Join expert panel Stephen Harrison, Maru Rinella MD and Mazen Noureddin, MD, MHSc as they discuss the practical implications of a NASH drug approval. Register here sonicincytes.com/webinar-regist…

Plain language summaries (PLSs) of Clinical Trial Results are a critical tool in medical communications to help disseminate summarized, easy-to-digest research information to general audiences. Here are our key insights into developing an effective PLS. bit.ly/43Me7ye

📣 Our research group currently has a number of vacanies. Please find the details on our lab webpage and come join us! whelanlab.co.uk/contact/ 📣

Tune in to episode 9 of the Global Nexus talk series "What Can I Do with my PhD?", featuring Coombes lab alum Bushra Ilyas talking about her exciting post-PhD career in medical writing.

Looking forward to sharing my experiences at Six Degrees Medical – A Reverba® Company and why #medcomms can be a rewarding career path after grad school!

Last week, SDMers gathered in person to celebrate the sunny season and enjoy each other's company. This year, we celebrated with SDMers in Toronto, Calgary, Montreal (Canada), and Manchester (UK)!

#PRESS Novo Nordisk product reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in trial

Join us at the CanadaAviationMuseum and Space Museum this Thursday and Friday! Earn your rovers drivers license on Thursday and your robotic arm operator certificate on Friday! Come early, spaces fill quickly! bit.ly/450o0bz

I can attest to that! Glad to see Six Degrees Medical – A Reverba® Company be recognized for everything the company does to keep employee satisfaction top of mind

Hot off the press, MAESTRO NAFLD results in Nature Medicine. Happy to be part of this landmark trial. Madrigal Pharmaceuticals Mazen Noureddin, MD, MHSc Anita Kohli @JinendraSatMD Alina Allen Jeffrey V. Lazarus Maru Rinella MD AASLD President Pinnacle Clinical Research Arizona Liver Health Gina Bartes nature.com/articles/s4159…

A call to all who do research on #hypoglycaemia 📢 Join the IHSG Advances in Hypoglycaemia Scientific Meeting and share your ideas with key opinion leaders in the field. Submit your abstracts here: cvent.com/c/abstracts/62… We look forward to hearing about your work!

We are seeking a skilled 𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐌𝐚𝐧𝐚𝐠𝐞𝐫 to join our team in Toronto. Additionally, we have two openings for 𝑺𝒆𝒏𝒊𝒐𝒓 𝑴𝒆𝒅𝒊𝒄𝒂𝒍 𝑾𝒓𝒊𝒕𝒆𝒓𝒔, with one position based in the United Kingdom. Visit our Careers page.

Are you an educator or facilitator teaching students between the grades of 6-9, looking for an out of this world #STEAM opportunity?! Check out the #RoverDrivingAcademy! Available Canada wide! 🇨🇦bit.ly/4dkN7cN

Breaking news. Sema hits both points for MASH resolution and Fibrosis improvement in the Ph 3 study! 62.9% vs 34.1% and 37% vs 22.5% respectively . Waiting to see F3, F2, titration and tolerance and drop out at #TLM24 #livertwitter Jörn Schattenberg Naim Alkhouri Rohit Loomba EASL Education